In addition, FZD2, FZD4, and FZD8 mRNA upregulation is also reported in human metastatic prostate cancer cell lines [99], and FZD2, FZD7, and FZD8 mRNA levels are increased in hormone depleted LNCaP cells [99]. Here, FZD2 is linked to metastatic prostate carcinoma.